Today on DrugResearcher.com   Biomarker market predicted to 'explode' Merck flexes muscle with GTx deal AstraZeneca CEO hacks at pipeline to up profits Preclinical services news in brief Sanofi pushes on with cell culture flu shot

Related Industry News   New counterfeit report highlights worrying trends DSM third quarter results New firm to tackle poor solubility head on New oral film takes the heat out of manufacturing

Breaking News on Drug Discovery
Daily  Wednesday 07 November 2007		Forward to a colleague

	Technical / White Paper Manufacturing Variations in Polysorbate Batches Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here Access Full Stories Biomarker market predicted to 'explode' The global market for biomarkers is expected to more than double over the next 5 years to reach an estimated $12.8bn (€8.7bn), according to a new market research report... Read Merck flexes muscle with GTx deal Merck & Co has inked a deal potentially worth over €507m (€346m) with GTx over a new class of drugs to treat muscle loss conditions, especially those caused by cancer... Read AstraZeneca CEO hacks at pipeline to up profits AstraZeneca's CEO has said the company will stop research in a number of diseases as it continues to cut costs and restructure in the face of falling sales... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, new deals have emerged involving MDS Pharma Services, Bruker Biospin and Expression Analysis... Read Sanofi pushes on with cell culture flu shot Sanofi Pasteur has kicked off Phase II trials of its cell culture-based seasonal flu vaccine in the US, part of a five year project with the US Department of Health and Human Services (HHS)... Read
	All News Headlines for: November | October | September
	Product Brochure Innovative New Shaking Incubator from Stuart® A compact bench top incubator can be just enough for bacterial cell culturing. The latest shaking incubator from Stuart® is packed with novel features such as BioCote antimicrobial protection:... Click Here
	Related Industry News New counterfeit report highlights worrying trends A new report highlights a number of worrying trends emerging in regard to the increasing number of fake pharmaceuticals infiltrating supply chains around the globe... Read DSM third quarter results DSM's third quarter financial results are paving the way for the company's transition to a life sciences and material sciences company... Read New firm to tackle poor solubility head on A new Belgian company has joined the throng of pharmas tapping into the booming drug delivery business, but claims that its unique technologies will carve it a place as one of the industry's key players... Read New oral film takes the heat out of manufacturing Another oral dissolvable film has been developed, with the formulation and manufacturing process potentially giving the strip a production advantage... Read Weekly Comment Big pharma lends a helping hand Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis. Read Product Presentation Rapid HPLC method development with ChromSword®Auto software Avoid the tedious search for good HPLC methods for separation with ChromSword®Auto's quicker chromatography solutions... Click Here Previous Headlines Why Pfizer's torcetrapib failure might not thwart other CETP inhibitors It was supposed to keep Pfizer at the top of the cardiovascular drug tree, but when torcetrapib failed, other pharma firms developing similar drugs looked on nervously to see if their drugs were also doomed. A... Read Mass spectrometry weighs in for genotyping applications Commonly the domain of the microarray, mass spectrometry is becoming an increasingly viable alternative for high throughput genotyping with recent research promising to advance its adoption... Read Apitope vaccine stops MS in its tracks UK biopharmaceutical firm Apitope has developed a vaccine that could halt multiple sclerosis in its relentless march to destroy nerve cells... Read Tecan and GE join forces to aid HT protein purification Tecan and GE Healthcare Life Sciences division are collaborating to simplify high throughput (HT) protein purification by increasing the speed and reliability of expression screening programmes... Read Charles River sails through Q3 Charles River Laboratories sailed through its third quarter, with comfortable gains in both revenue and profits... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers ZIC®-HILIC Separation of Polar and Hydrophilic Compounds - Product Presentation DAICEL chiral chromatography products - Company Profile Rapid HPLC method development with ChromSword®Auto software - Product Presentation Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com